The Menarini Group is the leading Italian pharmaceutical multinational, a privately owned biopharmaceutical company with more than 135 years of history. Founded in 1886 in Naples as “Farmacia Internazionale,” the company moved its headquarters to Florence, Italy, in 1915, where it remains today. As of 2025, Menarini is ranked as the 17th largest pharmaceutical laboratory in Europe and the 32nd largest in the world.

Key Corporate Information

Presence:
Operates in 140 countries across Europe, Asia, Africa, the Middle East, Central America, and the United States.

Workforce:
Employs over 17,000 professionals worldwide.

Financials:
Reported a turnover of approximately €4.37 billion.

Manufacturing:
Maintains 18 manufacturing plants that produce more than 609 million packets of product annually.

Research & Development:
Operates 9 R&D centers focused on therapeutic areas with unresolved pathologies, particularly oncology and anti-infectives.

Specialized Divisions

The Group is organized into three primary divisions to manage its extensive lifecycle of pharmaceutical and diagnostic solutions:

Menarini Ricerche:
Handles all R&D activities, from initial project creation through to drug registration.

Menarini Biotech:
Manages the development and industrial production of biotechnological drugs, including monoclonal antibodies, and offers CDMO services to external clients.

Menarini Diagnostics:
Focuses on developing instruments for clinical chemistry, diabetes management, hematology, histology, and immunology. It is also developing advanced technologies for rare tumor cell analysis.

Core Therapeutic Areas

Menarini’s product portfolio and research pipeline span several critical healthcare fields:

Cardiology:
Treatments for hypertension, angina pectoris, and heart failure.

Oncology:
Recently expanded into the US oncology market through the acquisition of Stemline Therapeutics.

Anti-Infectives:
Focus on Antimicrobial Resistance (AMR).

Consumer Healthcare:
Includes analgesics, food supplements, and cough/cold treatments.

Others:
Gastroenterology, pneumology, dermatology, aesthetics (RELIFE franchise), urology, and diabetes.
Business Strategy and Values

The company operates under a “fully integrated” model, managing everything from clinical development and regulatory approval to manufacturing and commercialization. A significant part of its growth strategy involves strategic partnering; Menarini positions itself as a partner of choice for biotech companies looking to launch products globally. Its corporate philosophy is built on four core values:
Patient Focus, People Care, Quality, and Ethics.